Search Results | Journal of Experimental Medicine

1-20 of 842 Search Results for

*

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Stopping the fat: Repurposing an antidepressant for cancer treatment

Deepika Bhullar, Cosimo Commisso

J Exp Med (2023) 220 (3): e20222097.

DOI: https://doi.org/10.1084/jem.20222097

Published: 02 February 2023

View article

Journal Articles

STING trafficking as a new dimension of immune signaling

Devon Jeltema, Kennady Abbott, Nan Yan

J Exp Med (2023) 220 (3): e20220990.

DOI: https://doi.org/10.1084/jem.20220990

Published: 27 January 2023

View article

Journal Articles

Gut microbiota biofilms: From regulatory mechanisms to therapeutic targets

Andre G. Buret, Thibault Allain

J Exp Med (2023) 220 (3): e20221743.

DOI: https://doi.org/10.1084/jem.20221743

Published: 23 January 2023

View article

Journal Articles

Sara Suliman: Science is better when it’s shared

Lucie Van Emmenis

J Exp Med (2023) 220 (2): e20230038.

DOI: https://doi.org/10.1084/jem.20230038

Published: 18 January 2023

View article

Journal Articles

Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease

Lawrence Steinman, Roberto Patarca, William Haseltine

J Exp Med (2023) 220 (2): e20221322.

DOI: https://doi.org/10.1084/jem.20221322

Published: 18 January 2023

View article

Includes: Supplementary data

Journal Articles

Engineering mighty microglia

Adeline E. Walsh, John R. Lukens

J Exp Med (2023) 220 (3): e20222070.

DOI: https://doi.org/10.1084/jem.20222070

Published: 17 January 2023

View article

Journal Articles

Microbiome influencers of checkpoint blockade–associated toxicity

In Special Collection:

Journal-Based CME Activities with Journal of Experimental Medicine (JEM)

Yinghong Wang, Robert R. Jenq, Jennifer A. Wargo, Stephanie S. Watowich

J Exp Med (2023) 220 (3): e20220948.

DOI: https://doi.org/10.1084/jem.20220948

Published: 09 January 2023

View article

Journal Articles

Targeting neuroinflammation in neuropathic pain and opioid use

Daniela Salvemini, Timothy M. Doyle

J Exp Med (2022) 220 (2): e20221244.

DOI: https://doi.org/10.1084/jem.20221244

Published: 23 December 2022

View article

Journal Articles

How decreasing T cell signaling unexpectedly results in autoimmunity

Jaeu Yi, Chyi-Song Hsieh

J Exp Med (2022) 220 (2): e20221886.

DOI: https://doi.org/10.1084/jem.20221886

Published: 15 December 2022

View article

Journal Articles

γδIL17 under control

Guillem Sanchez Sanchez, David Vermijlen

J Exp Med (2022) 220 (2): e20221921.

DOI: https://doi.org/10.1084/jem.20221921

Published: 15 December 2022

View article

Journal Articles

CSF-to-dura gateways

Jean-Leon Thomas, Helene Benveniste

J Exp Med (2022) 220 (2): e20221719.

DOI: https://doi.org/10.1084/jem.20221719

Published: 06 December 2022

View article

Journal Articles

Lectin recruits pathogenic bugs

Charles R. Schutt, Sho Yamasaki

J Exp Med (2022) 220 (1): e20221732.

DOI: https://doi.org/10.1084/jem.20221732

Published: 22 November 2022

View article

Journal Articles

Friend turned foe: TREM2 agonist in battles against tau

Gillian Carling, Wenjie Luo, Li Gan

J Exp Med (2022) 220 (1): e20221850.

DOI: https://doi.org/10.1084/jem.20221850

Published: 18 November 2022

View article

Journal Articles

NLRP1 activation by UVB: Shedding light on an enigmatic inflammasome

Andrew Sandstrom

J Exp Med (2022) 220 (1): e20221720.

DOI: https://doi.org/10.1084/jem.20221720

Published: 14 November 2022

View article

Journal Articles

The X factor in neurodegeneration

Rhonda Voskuhl, Yuichiro Itoh

J Exp Med (2022) 219 (12): e20211488.

DOI: https://doi.org/10.1084/jem.20211488

Published: 04 November 2022

View article

Journal Articles

Challenges in TB research

Thomas J. Scriba, Ryan Dinkele, Digby F. Warner, Valerie Mizrahi

J Exp Med (2022) 219 (12): e20221334.

DOI: https://doi.org/10.1084/jem.20221334

Published: 03 November 2022

View article

Journal Articles

Metabolic features of innate lymphoid cells

Huiyang Yu, Nicolas Jacquelot, Gabrielle T. Belz

J Exp Med (2022) 219 (11): e20221140.

DOI: https://doi.org/10.1084/jem.20221140

Published: 27 October 2022

View article

Journal Articles

Eating away T cell responses in lung cancer

Roberto Ferrara, Luca Roz

J Exp Med (2022) 219 (12): e20221449.

DOI: https://doi.org/10.1084/jem.20221449

Published: 10 October 2022

View article

Journal Articles

CARD8 makes coxsackievirus more “heartbreaking”

Qiankun Wang, Liang Shan

J Exp Med (2022) 219 (10): e20221240.

DOI: https://doi.org/10.1084/jem.20221240

Published: 21 September 2022

View article

Journal Articles

Innatus immunis: Evolving paradigm of adaptive NK cells

Mohamed Khalil, Subramaniam Malarkannan

J Exp Med (2022) 219 (11): e20221254.

DOI: https://doi.org/10.1084/jem.20221254

Published: 06 September 2022

View article

2 3 4 5

NARROW

Filters

*

Stopping the fat: Repurposing an antidepressant for cancer treatment

STING trafficking as a new dimension of immune signaling

Gut microbiota biofilms: From regulatory mechanisms to therapeutic targets

Sara Suliman: Science is better when it’s shared

Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease

Engineering mighty microglia

Microbiome influencers of checkpoint blockade–associated toxicity

Targeting neuroinflammation in neuropathic pain and opioid use

How decreasing T cell signaling unexpectedly results in autoimmunity

γδIL17 under control

CSF-to-dura gateways

Lectin recruits pathogenic bugs

Friend turned foe: TREM2 agonist in battles against tau

NLRP1 activation by UVB: Shedding light on an enigmatic inflammasome

The X factor in neurodegeneration

Challenges in TB research

Metabolic features of innate lymphoid cells

Eating away T cell responses in lung cancer

CARD8 makes coxsackievirus more “heartbreaking”

Innatus immunis: Evolving paradigm of adaptive NK cells

Email alerts

*

Email alerts

This Feature Is Available To Subscribers Only